[HTML] sciencedirect.com

[HTML][HTML] Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity

B Navarro-Almenzar, JJ Cerezo-Manchado… - IJC Heart & …, 2021 - Elsevier
Background Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the main
cause of anticoagulation, being direct oral anticoagulants (DOAC) increasingly used in this …
被引用次数：13 相关文章

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity.

B Navarro-Almenzar, JJ Cerezo-Manchado… - … Journal of cardiology …, 2021 - europepmc.org
Background Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the main
cause of anticoagulation, being direct oral anticoagulants (DOAC) increasingly used in this …
[HTML] nih.gov

[HTML][HTML] Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity

B Navarro-Almenzar, JJ Cerezo-Manchado… - … Journal of Cardiology …, 2021 - ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the main
cause of anticoagulation, being direct oral anticoagulants (DOAC) increasingly used in this …

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity

B Navarro-Almenzar… - … cardiology. Heart & …, 2021 - pubmed.ncbi.nlm.nih.gov
Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the main cause of
anticoagulation, being direct oral anticoagulants (DOAC) increasingly used in this context …